EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 3.0

Phage Therapy: A Different Approach to Fight Bacterial Infections

Zigale Hibstu iD, Habtamu Belew iD, Yibeltal Akelew iD, Hylemariam Mihiretie Mengist iD

Biologics: Targets and Therapy · 2022-10 · Volume 16 · 173-186

DOI: 10.2147/btt.s381237 ↗

At a glance

Übersichtsarbeit in Biologics: Targets and Therapy, 2022-10. Written by Zigale Hibstu and 3 co-authors. Institution: Department of Medical Laboratory Science, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia. Cited 106 times so far (Crossref); 104 references. The full text is freely available (open access, CC BY-NC 3.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Phage therapy is one of the alternatives to treat infections caused by both antibiotic-sensitive and antibiotic-resistant bacteria, with no or low toxicity to patients. It was started a century ago, although rapidly growing bacterial antimicrobial resistance, resulting in high levels of morbidity, mortality, and financial cost, has initiated the revival of phage therapy. It involves the use of live lytic, bioengineered, phage-encoded biological products, in combination with chemical antibiotics to treat bacterial infections. Importantly, phages will be removed from the body within seven days of clearing an infection. They target specific bacterial strains and cause minimal disruption to the microbial balance in humans. Phages for medication must be screened for the absence of resistant genes, virulent genes, cytotoxicity, and their interaction with the host tissue and organs. Since they are immunogenic, applying a high phage titer for therapy exposes them and activates the host immune system. To date, no serious side effects have been reported with human phage therapy. In this review, we describe phage-phagocyte interaction, bacterial resistance to phages, how phages conquer bacterial resistance, the role of genetic engineering and other technologies in phage therapy, and the therapeutic application of modified phages and phage-encoded products. We also highlight the comparison of antibiotics and lytic phage therapy, the pros and cons of phage therapy, determinants of human phage therapy trials, phage quality and safety requirements, phage storage and handling, and current challenges in phage therapy.

Subjects

Author keywords

CRISPRconquering CRISPRimmunitylysogenizationlytic phagemodified phagesphage-encoded productsresistance to phages

Authors and institutions

  • Department of Medical Laboratory Science, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.

ORCID profiles: Zigale Hibstu, Habtamu Belew, Yibeltal Akelew, Hylemariam Mihiretie Mengist

Cite

APA

Hibstu, Z., Belew, H., Akelew, Y., & Mengist, H. M. (2022). Phage Therapy: A Different Approach to Fight Bacterial Infections. Biologics: Targets and Therapy, Volume 16, 173-186. https://doi.org/10.2147/btt.s381237

Vancouver

Hibstu Z, Belew H, Akelew Y, Mengist HM. Phage Therapy: A Different Approach to Fight Bacterial Infections. Biologics: Targets and Therapy. 2022;Volume 16:173-186. doi:10.2147/btt.s381237

BibTeX
@article{Hibstu2022,
  author = {Hibstu, Zigale and Belew, Habtamu and Akelew, Yibeltal and Mengist, Hylemariam Mihiretie},
  title = {Phage Therapy: A Different Approach to Fight Bacterial Infections},
  journal = {Biologics: Targets and Therapy},
  year = {2022},
  volume = {Volume 16},
  pages = {173--186},
  doi = {10.2147/btt.s381237}
}
Start for free →